Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies

Year Immunol. 1993:7:213-9.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antibodies, Monoclonal / biosynthesis*
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / isolation & purification
  • B-Lymphocytes / cytology*
  • B-Lymphocytes / immunology
  • Cell Division
  • Cell Fusion
  • Cell Line, Transformed / drug effects
  • Chromosomes, Human
  • Culture Media / pharmacology
  • Hepatitis B Antibodies / biosynthesis*
  • Hepatitis B Antibodies / immunology
  • Hepatitis B Antibodies / isolation & purification
  • Hepatitis B Core Antigens / immunology*
  • Herpesvirus 4, Human
  • Humans
  • Hybrid Cells / drug effects
  • Hybrid Cells / pathology
  • Hybridomas / drug effects
  • Hybridomas / immunology
  • Hybridomas / pathology*
  • Hypoxanthine Phosphoribosyltransferase / genetics
  • Immunoglobulin M / biosynthesis
  • Immunoglobulin M / immunology
  • Mice
  • Multiple Myeloma / pathology*
  • Ouabain / pharmacology
  • Recombinant Proteins / immunology
  • Selection, Genetic
  • Thioguanine / pharmacology
  • Tumor Cells, Cultured / drug effects

Substances

  • Antibodies, Monoclonal
  • Culture Media
  • Hepatitis B Antibodies
  • Hepatitis B Core Antigens
  • Immunoglobulin M
  • Recombinant Proteins
  • Ouabain
  • Hypoxanthine Phosphoribosyltransferase
  • Thioguanine